financetom
Business
financetom
/
Business
/
Market Chatter: Apollo Plans to Raise $10 Billion From Insurers via Special-Purpose Vehicle
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Apollo Plans to Raise $10 Billion From Insurers via Special-Purpose Vehicle
Sep 18, 2025 6:15 AM

08:39 AM EDT, 09/18/2025 (MT Newswires) -- Apollo (APO) is planning to raise about $10 billion from insurers through a special-purpose vehicle that would sell debt backed by stakes in its credit funds, Bloomberg reported Thursday, citing people familiar with the matter.

The notes will be secured against interests in a range of Apollo credit funds, including direct lending, asset-based finance, hybrid capital, and investment-grade credit, according to the report.

The potential transaction is at an early stage and terms remain under discussion with investors, the report said.

Approximately one third of US life insurance companies' cash and invested assets of $6 trillion were tied to various forms of private credit by the end of 2024, the report said, citing Moody's estimates.

Apollo did not immediately respond to MT Newswires' request for comment.

Shares of Apollo were up 1.1% in recent Thursday premarket activity.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Albemarle to divest Ketjen control, Eurecat stake in $660 million deal
Albemarle to divest Ketjen control, Eurecat stake in $660 million deal
Oct 27, 2025
(Reuters) -Albemarle said on Monday it will sell a 51% stake in its refining catalyst solutions business, Ketjen, to private equity firm KPS Capital Partners, and divest its 50% interest in the Eurecat joint venture to France's Axens SA, in deals worth about $660 million. Albemarle, one of the world's largest lithium producers, said it would use the proceeds for...
EINC to Divest Two U.S. Auction Sites
EINC to Divest Two U.S. Auction Sites
Oct 27, 2025
Company to Focus on Licensing Technology and Canadian Growth TORONTO, Oct. 27, 2025 /PRNewswire/ - E Automotive Inc. (EINC or the Company), a leader in automotive wholesale solutions offered under the brands EBlock, EDealer and Cars.ca, today announces the divestment of certain non-core US assets including its New Orleans and Houston physical auctions by way of an asset purchase agreement...
Eli Lilly Says Omvoh Shows Early, Sustained Improvement in Bowel Urgency in Ulcerative Colitis Patients
Eli Lilly Says Omvoh Shows Early, Sustained Improvement in Bowel Urgency in Ulcerative Colitis Patients
Oct 27, 2025
07:37 AM EDT, 10/27/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Monday that Omvoh-treated patients with moderately to severely active ulcerative colitis saw early improvements in bowel urgency severity, frequency and stool deferral time by week 12, with the results continuing to improve through 28 weeks. Results from a Phase 3b trial showed that bowel urgency severity was...
Intellia pauses late-stage trials of gene-editing treatment after serious liver event
Intellia pauses late-stage trials of gene-editing treatment after serious liver event
Oct 27, 2025
Oct 27 (Reuters) - Intellia Therapeutics ( NTLA ) said on Monday it has temporarily stopped dosing and screening patients in two late-stage studies of its one-time gene-editing treatment for a heart condition after a patient experienced a serious liver problem. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved